119 related articles for article (PubMed ID: 35920832)
21. The A Allele at rs13419896 of EPAS1 Is Associated with Enhanced Expression and Poor Prognosis for Non-Small Cell Lung Cancer.
Putra AC; Eguchi H; Lee KL; Yamane Y; Gustine E; Isobe T; Nishiyama M; Hiyama K; Poellinger L; Tanimoto K
PLoS One; 2015; 10(8):e0134496. PubMed ID: 26263511
[TBL] [Abstract][Full Text] [Related]
22. Protein phosphatase 1 regulatory subunit 3G (PPP1R3G) correlates with poor prognosis and immune infiltration in lung adenocarcinoma.
Zhuo X; Chen L; Lai Z; Liu J; Li S; Hu A; Lin Y
Bioengineered; 2021 Dec; 12(1):8336-8346. PubMed ID: 34592886
[TBL] [Abstract][Full Text] [Related]
23. Frequent epigenetic inactivation of deleted in lung and esophageal cancer 1 gene by promoter methylation in non-small-cell lung cancer.
Zhang Y; Miao Y; Yi J; Wang R; Chen L
Clin Lung Cancer; 2010 Jul; 11(4):264-70. PubMed ID: 20630829
[TBL] [Abstract][Full Text] [Related]
24. Methylation markers of early-stage non-small cell lung cancer.
Lokk K; Vooder T; Kolde R; Välk K; Võsa U; Roosipuu R; Milani L; Fischer K; Koltsina M; Urgard E; Annilo T; Metspalu A; Tõnisson N
PLoS One; 2012; 7(6):e39813. PubMed ID: 22768131
[TBL] [Abstract][Full Text] [Related]
25. Promoter methylation-mediated silencing of β-catenin enhances invasiveness of non-small cell lung cancer and predicts adverse prognosis.
Miao Y; Wang L; Zhang X; Xu X; Jiang G; Fan C; Liu Y; Lin X; Yu J; Zhang Y; Wang E
PLoS One; 2014; 9(11):e112258. PubMed ID: 25396757
[TBL] [Abstract][Full Text] [Related]
26. Clinicopathological significance of DAPK gene promoter hypermethylation in non-small cell lung cancer: A meta-analysis.
Chen Z; Fan Y; Liu X; Shang X; Qi K; Zhang S
Int J Biol Markers; 2022 Mar; 37(1):47-57. PubMed ID: 34935548
[TBL] [Abstract][Full Text] [Related]
27. Validation of SCT Methylation as a Hallmark Biomarker for Lung Cancers.
Zhang YA; Ma X; Sathe A; Fujimoto J; Wistuba I; Lam S; Yatabe Y; Wang YW; Stastny V; Gao B; Larsen JE; Girard L; Liu X; Song K; Behrens C; Kalhor N; Xie Y; Zhang MQ; Minna JD; Gazdar AF
J Thorac Oncol; 2016 Mar; 11(3):346-360. PubMed ID: 26725182
[TBL] [Abstract][Full Text] [Related]
28. Endothelial PAS domain protein 1 gene hypomethylation is associated with colorectal cancer in Han Chinese.
Pan R; Zhou C; Dai J; Ying X; Yu H; Zhong J; Zhang Y; Wu B; Mao Y; Wu D; Ying J; Zhang W; Duan S
Exp Ther Med; 2018 Dec; 16(6):4983-4990. PubMed ID: 30542453
[TBL] [Abstract][Full Text] [Related]
29. Interferon Consensus Sequence-Binding Protein 8, a Tumor Suppressor, Suppresses Tumor Growth and Invasion of Non-Small Cell Lung Cancer by Interacting with the Wnt/β-Catenin Pathway.
Ye L; Xiang T; Zhu J; Li D; Shao Q; Peng W; Tang J; Li L; Ren G
Cell Physiol Biochem; 2018; 51(2):961-978. PubMed ID: 30466106
[TBL] [Abstract][Full Text] [Related]
30. Bioinformatics Analysis Identifies EPAS1 as a Novel Prognostic Marker Correlated with Immune Infiltration in Acute Myeloid Leukemia.
Wang S; Zhang P
Dis Markers; 2023; 2023():6072782. PubMed ID: 37124944
[TBL] [Abstract][Full Text] [Related]
31. Gender difference in estrogen receptor alpha promoter hypermethylation and its prognostic value in non-small cell lung cancer.
Lai JC; Cheng YW; Chiou HL; Wu MF; Chen CY; Lee H
Int J Cancer; 2005 Dec; 117(6):974-80. PubMed ID: 15986439
[TBL] [Abstract][Full Text] [Related]
32. Prognostic value of Iroquois homeobox 1 methylation in non-small cell lung cancers.
Lee JY; Lee WK; Park JY; Kim DS
Genes Genomics; 2020 May; 42(5):571-579. PubMed ID: 32200543
[TBL] [Abstract][Full Text] [Related]
33. Promoter methylation of APC and RAR-β genes as prognostic markers in non-small cell lung cancer (NSCLC).
Feng H; Zhang Z; Qing X; Wang X; Liang C; Liu D
Exp Mol Pathol; 2016 Feb; 100(1):109-13. PubMed ID: 26681652
[TBL] [Abstract][Full Text] [Related]
34. Adenomatous polyposis coli gene promoter hypermethylation in non-small cell lung cancer is associated with survival.
Brabender J; Usadel H; Danenberg KD; Metzger R; Schneider PM; Lord RV; Wickramasinghe K; Lum CE; Park J; Salonga D; Singer J; Sidransky D; Hölscher AH; Meltzer SJ; Danenberg PV
Oncogene; 2001 Jun; 20(27):3528-32. PubMed ID: 11429699
[TBL] [Abstract][Full Text] [Related]
35. Low expression of ITIH5 in adenocarcinoma of the lung is associated with unfavorable patients' outcome.
Dötsch MM; Kloten V; Schlensog M; Heide T; Braunschweig T; Veeck J; Petersen I; Knüchel R; Dahl E
Epigenetics; 2015; 10(10):903-12. PubMed ID: 26252352
[TBL] [Abstract][Full Text] [Related]
36. [RUNX3 promoter hypermethylation and prognosis of early surgically resected non-small cell lung cancers].
Tang Y; Wu F; Hu C
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Jul; 36(7):650-4. PubMed ID: 21873791
[TBL] [Abstract][Full Text] [Related]
37. Quantitative O(6)-methylguanine DNA methyltransferase methylation analysis in curatively resected non-small cell lung cancer: associations with clinical outcome.
Brabender J; Usadel H; Metzger R; Schneider PM; Park J; Salonga D; Tsao-Wei DD; Groshen S; Lord RV; Takebe N; Schneider S; Hölscher AH; Danenberg KD; Danenberg PV
Clin Cancer Res; 2003 Jan; 9(1):223-7. PubMed ID: 12538473
[TBL] [Abstract][Full Text] [Related]
38. Promoter methylation of Wnt antagonist DKK1 gene and prognostic value in Korean patients with non-small cell lung cancers.
Na Y; Lee SM; Kim DS; Park JY
Cancer Biomark; 2012; 12(2):73-9. PubMed ID: 23396252
[TBL] [Abstract][Full Text] [Related]
39. Promoter hypermethylation of the CFTR gene and clinical/pathological features associated with non-small cell lung cancer.
Son JW; Kim YJ; Cho HM; Lee SY; Lee SM; Kang JK; Lee JU; Lee YM; Kwon SJ; Choi E; Na MJ; Park JY; Kim DS
Respirology; 2011 Nov; 16(8):1203-9. PubMed ID: 21585618
[TBL] [Abstract][Full Text] [Related]
40. [Prognostic value of methylation status of RASSF1A gene as an independent factor of non-small cell lung cancer].
Zhang H; Zhang S; Zhang Z; Jia H; Gu S; Zhao D
Zhongguo Fei Ai Za Zhi; 2010 Apr; 13(4):311-6. PubMed ID: 20677556
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
